WO2026033421 - IDENTIFICATION OF SUITABLE DONORS OF γδ T CELLS
National phase entry is expected:
Publication Number
WO/2026/033421
Publication Date
12.02.2026
International Application No.
PCT/IB2025/057986
International Filing Date
05.08.2025
Title **
[English]
IDENTIFICATION OF SUITABLE DONORS OF γδ T CELLS
[French]
IDENTIFICATION DE DONNEURS APPROPRIÉS DE LYMPHOCYTES T γδ
Applicants **
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors
KARANDIKAR, Sukrut
GU, Gary
SOBHANA, Nandhu
MISHRA, Rabi
VAIDYA, Shantashri
JOSHI, Priyanka
Priority Data
63/679,552
05.08.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2978 | |
| EPO | Filing, Examination, Granting | 23672 | |
| Japan | Filing, Examination, Granting | 3079 | |
| South Korea | Filing, Examination, Granting | 3945 | |
| USA | Filing, Examination, Granting | 9740 |
Total:
43,414
Contact Us
Abstract[English]
γδ T cells in the donor blood sample by detecting the presence of cells that express CD27, CD127, CD73, or any combination thereof. Further provided are populations of γδ T cells obtained from the suitable donor blood sample and methods of using the same.[French]
γδ naïfs dans l'échantillon de sang donneur par détection de la présence de cellules qui expriment CD27, CD127, CD73, ou n'importe quelle combinaison de ceux-ci. L'invention concerne en outre des populations de lymphocytes T γδ obtenus à partir de l'échantillon de sang donneur approprié et des méthodes d'utilisation de celles-ci.